Overview
John Glod is a Pediatric Hematologist Oncology provider in New Brunswick, New Jersey. Dr. Glod is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Neurofibromatosis Type 1 (NF1), Adult Soft Tissue Sarcoma, Neurofibromatosis, Brain Stem Cancer, and Thyroidectomy.
His clinical research consists of co-authoring 63 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles and participated in 2 clinical trials in the study of Diffuse Midline Glioma H3 K27M-Mutant.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Additional Areas of Focus
Dr. Glod has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
17 Clinical Trials
Ira Dunkel is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Dunkel is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Retinoblastoma, Diffuse Midline Glioma H3 K27M-Mutant, Glioma, and Brain Stem Cancer.
Cassie Kline is a Pediatric Hematologist Oncology provider in Philadelphia, Pennsylvania. Dr. Kline is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. Her top areas of expertise are Diffuse Midline Glioma H3 K27M-Mutant, Glioma, Brain Stem Cancer, and Medulloblastoma.
Kim Kramer is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Kramer is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. Her top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Neuroblastoma, Diffuse Midline Glioma H3 K27M-Mutant, and Medulloblastoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Soft Tissue SarcomaDr. Glod isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Neurofibromatosis Type 1 (NF1)Dr. Glod isDistinguished. Learn about Neurofibromatosis Type 1 (NF1).
- Advanced
- Brain Stem CancerDr. Glod isAdvanced. Learn about Brain Stem Cancer.
- Diffuse Midline Glioma H3 K27M-Mutant
- Embryonal Tumor with Multilayered Rosettes
- Ewing SarcomaDr. Glod isAdvanced. Learn about Ewing Sarcoma.
- NeurofibromatosisDr. Glod isAdvanced. Learn about Neurofibromatosis.
- OsteosarcomaDr. Glod isAdvanced. Learn about Osteosarcoma.
- Experienced
- Denys-Drash Syndrome (DDS)Dr. Glod isExperienced. Learn about Denys-Drash Syndrome (DDS).
- GliomaDr. Glod isExperienced. Learn about Glioma.
- HepatoblastomaDr. Glod isExperienced. Learn about Hepatoblastoma.
- HistiocytosisDr. Glod isExperienced. Learn about Histiocytosis.
- Infantile NeutropeniaDr. Glod isExperienced. Learn about Infantile Neutropenia.
- IntersexDr. Glod isExperienced. Learn about Intersex.